Imagine if there was a way to resolve two of the most intractable challenges in the 340B program in one fell swoop: one that has a significant impact on the financial health of 340B providers, and another that affects the pharmaceutical industry’s bottom line? It may be hard to imagine, but there is now a bill in Congress that can be welcomed by both the 340B covered entity community and the drug industry.
Pharmacy transformations are happening every day. As leaders, we need to identify the challenges that need to be addressed in order to not only deliver improved patient care, but to elevate clinician satisfaction, and optimize pharmacy performance.
By connecting medication inventory and leveraging the data pulled from that technology, there is a huge opportunity to reduce error, improve efficiency, control costs, ensure compliance and, ultimately, enhance patient care and safety.
With drug costs skyrocketing and the ever-present challenge of drug shortages, throwing away medications can be agonizing. And costly. The more visibility you have into your inventory, the better equipped you are to eliminate medication waste and ensure clinicians have access to the medications patients need.
The daily job of a pharmacist can be full of time-consuming manual processes. Inefficient workflows and lack of data visibility compound Pharmacy challenges. Leveraging medication inventory management tools are helping many health systems like Wellforce to improve efficiency through automated workflows and real-time data that allow pharmacists to provide top of license care.
Hospitals that continue to manually manage medications in the central pharmacy are playing a dangerous game. Inevitably a medication management error will happen. Yet for many hospitals, the fear of change keeps many pharmacies stuck with archaic solutions and processes that inevitably lead to problems.
After a long period of treading water, recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting. A close review of recent government court filings also provides a strong endorsement for a key but highlydebated tenet of the 340B program.
The recent State of Pharmacy Compounding survey found that outsourcing for CSPs continues to remain high. But with disruption and uncertainty in the safety and supply of outsourced compounded IV medication, insourcing with IV technology is a strategy that health systems need to consider.
Pharmacists are consistently ranked among the top-most trusted professions. But under-utilization of the pharmacist is resulting in a significant lost opportunity for clinical excellence and patient satisfaction. The digital transformation of healthcare is the opportunity for pharmacy to move back to the center of culturally competent patient care.
The Autonomous Pharmacy Advisory Board has coalesced around the clear vision of a fully autonomous pharmacy. Recent AJHP commentary details a framework that identifies five levels of increasing technological capability and work process improvement spanning nine pharmacy work processes. The ultimate goal is near error-free medication management that optimizes the benefits and minimizes the harm and costs of medication use.
The Autonomous Pharmacy can help to solve clinical and operational challenges. But gaining organizational support and approval for the technology investment can be complex and challenging to navigate; solid Value Justification can demonstrate the transformational value for health system leadership.
Advances in cloud computing and its adoption make it possible and powerful for the pharmacy data to be integrated into the overall health system, care continuum, and patient journey. Cloud is also empowering pharmacists to leverage predictive analytics and benchmarking to accurately optimize medication inventory management through quality, trusted data.
The benefits of a fully autonomous pharmacy are widely recognized – reduced medication errors, less waste, improved efficiencies, more opportunity to focus on higher-value patient care. Yet many pharmacies are still putting off the adoption of autonomous solutions.
Since the Affordable Care Act (ACA) was enacted a decade ago, most 340B provider advocates have preached caution, as 340B providers scored significant victories in the ACA. These wins included expanding the 340B program to include rural hospitals, increasing pricing transparency and providing additional oversight over drug manufacturers. Ever since, 340B advocates have been largely playing defense – reacting, rather than setting the agenda.
I invite you to join us during ASHP Midyear 2020 to learn how the Autonomous Pharmacy is transforming inefficient, error-prone, manual processes to help pharmacies enhance safety, improve efficiency, and drive business outcomes.
In many other industries we’ve seen success in how technology is accelerating and transforming the way products and services are created, delivered, consumed, and measured. Despite the pace of change elsewhere, health system pharmacy continues to lag in investing in and implementing transformational technology.
Every day, the healthcare industry faces new challenges that are impeding goals to deliver quality patient care. The stress of managing more complex systems in the face of higher expectations continues to grow.
As news emerged about positive COVID-19 vaccine trial results, the attention turned to how the vaccine would be distributed and administered to 330 million Americans. EnlivenHealth™ explored these COVID-19 vaccine readiness issues in a recent national survey.
The operating room is one of the most intense and dynamic environments across any health system. It is also one of the more costly areas while at the same time being one of the highest revenue-generating functions.
Omnicell 340B Guest Contributor Ted Slafsky shares his perspective on the threat to the 340B drug program as some drug manufacturers have unilaterally stopped providing 340B discounts, how advocacy groups are stepping up to defend the long-standing right to dispense drugs through contract pharmacies.
Omnicell’s Winter 2020 release includes new advancements in automation, intelligence, and technology-enabled services to streamline workflows and expand inventory management capabilities to drive improved outcomes and operational success. Read more about the Company’s product roadmap and strategic vision.
Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.
What if critical operational data, such as early detection of potential inventory excess, medication transactions and movement, and pharmacy technician activity, could be tracked and reviewed? If you could see soon to be expired medications and base future purchasing decisions on past buying behavior - that would be pretty powerful and fiscally advantageous.
While the accuracy of IV preparations is widely recognized as a safety and cost issue, the industry is still slow in adopting technology solutions that support greater accuracy and sterility. That’s why ISMP recently conducted the first survey in more than 20 years specifically focused on IV accuracy.
We all know the importance of ensuring that syringes are labeled whenever medications are prepared but not immediately administered. Yet this important medication safety step often gets omitted due to immediate patient care needs.
The concept of the autonomous pharmacy — the vision to eliminate all manual tasks regarding medication dispensing and IV preparation — is a direct response to escalating challenges in medication and supply management across the continuum of care.
You need uniform connectivity across your pharmacy operating systems to have a complete view of your inventory and the medication’s journey. This will help your hospital streamline workflows, achieve closed loop reporting, reduce medication errors, limit diversion risk, lower costs, and improve patient care.
Could you imagine having complete visibility across your pharmacy operation? For instance, the ability to track medication – from the loading dock to the nurse’s glove – through a combination of cloud-based intelligence, analytics, machine learning, and AI.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.